Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation”

3 trials

Showing 3 of 3 results

Not applicableApproved For MarketingNCT04972487
What this trial is testing

Expanded Access Program for Tofersen in Participants With Superoxide Dismutase 1-Amyotropic Lateral Sclerosis

Who this might be right for
Superoxide Dismutase 1-Amyotropic Lateral Sclerosis
Biogen
Post-approval studies (Phase 4)Active Not RecruitingNCT07223723
What this trial is testing

Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04856982
What this trial is testing

BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

Who this might be right for
Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation
Biogen 158

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation